BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37142816)

  • 21. Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling.
    Takahashi S; Noro R; Seike M; Zeng C; Matsumoto M; Yoshikawa A; Nakamichi S; Sugano T; Hirao M; Matsuda K; Hamada M; Gemma A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ 003390/Eukaryotic translation initiation factor 4A3 promoted cell migration and proliferation in endometrial cancer via vascular endothelial growth factor signaling by miR-195-5p.
    Ma J; Zhao X; Shi L
    Bioengineered; 2022 May; 13(5):11958-11972. PubMed ID: 35546509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of circular RNA hsa_circ_0087856 sensitizes bladder cancer cells to cisplatin through targeting miR-1184/CITED2 signaling.
    Ju M; Wu W; Qu J; Sun Y; Li J
    Environ Mol Mutagen; 2023 Jul; 64(6):342-353. PubMed ID: 37392146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.
    Yang M; Hu H; Wu S; Ding J; Yin B; Huang B; Li F; Guo X; Han L
    J Exp Clin Cancer Res; 2022 May; 41(1):165. PubMed ID: 35513835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
    Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
    Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.
    Ogihara K; Kikuchi E; Okazaki S; Hagiwara M; Takeda T; Matsumoto K; Kosaka T; Mikami S; Saya H; Oya M
    Cancer Sci; 2019 Apr; 110(4):1431-1441. PubMed ID: 30719824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JUND-dependent up-regulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer.
    Peng Y; Chen Y; Chen S; Wang J; Jiang C; Hou W; Xu C
    J Biochem; 2020 Jul; 168(1):73-82. PubMed ID: 32240302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer.
    Gong P; Xu R; Zhuang Q; He X
    Biomed Pharmacother; 2020 Jun; 126():110059. PubMed ID: 32208321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-κB/bone remodeling factors signaling.
    Xu Y; Zhang S; Liao X; Li M; Chen S; Li X; Wu X; Yang M; Tang M; Hu Y; Li Z; Yu R; Huang M; Song L; Li J
    Mol Cancer; 2021 Jul; 20(1):98. PubMed ID: 34325714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3.
    Qin Y; Zheng Y; Huang C; Li Y; Gu M; Wu Q
    BMC Cancer; 2021 Nov; 21(1):1172. PubMed ID: 34727877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR.
    Li X; Wang C; Chen G; Zou W; Deng Y; Zhou F
    Metab Brain Dis; 2022 Mar; 37(3):819-833. PubMed ID: 35038081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer.
    Hu B; Chen R; Jiang M; Xiong S; Liu X; Fu B
    PeerJ; 2023; 11():e15309. PubMed ID: 37180585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
    Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
    Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3.
    Wang X; Chen M; Fang L
    Mol Ther Nucleic Acids; 2021 Dec; 26():122-134. PubMed ID: 34513299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3.
    Xu B; Yang N; Liu Y; Kong P; Han M; Li B
    Med Sci Monit; 2020 Aug; 26():e923876. PubMed ID: 32857753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis.
    Huang X; Tan W; Liu Z; Fu X; Li Z; Lai S; Li Q; Zhong X; Qu F; Zhang H; Li H
    Life Sci; 2023 Jul; 324():121745. PubMed ID: 37127184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance.
    Chi BJ; Zhao DM; Liu L; Yin XZ; Wang FF; Bi S; Gui SL; Zhou SB; Qin WB; Wu DM; Wang SQ
    Neoplasma; 2019 Mar; 66(2):197-202. PubMed ID: 30509102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.